Notify me when Forbion Capital Fund IV Cooperatief U.A. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Company N.V. | Ordinary Shares, Nominal value 0.12 per share | 8.3% | $223,140,090 | -$30,222,313 | 9,316,914 | -12% | ForGrowth NAP B.V. | 26 Sep 2025 |
| DYN | Dyne Therapeutics, Inc. | Common Stock, par value $0.0001 | 4.8% | $60,000,055 | 5,400,545 | ForDyne B.V. | 31 Mar 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|